{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:32:51Z","timestamp":1786116771996,"version":"build-2736575974"},"posted":{"date-parts":[[2026,8,4]]},"group-title":"Epidemiology","reference-count":35,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,8,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>\n                    Enteric fever, caused by\n                    <jats:italic>Salmonella enterica<\/jats:italic>\n                    serovars Typhi and Paratyphi, remains a major cause of morbidity in low- and middle-income countries, yet burden estimation is challenging in regions without blood culture surveillance. Azithromycin is effective for treating enteric fever, and mass drug administration (MDA) to young children reduces all-cause mortality in sub-Saharan Africa, but its impact on community-level enteric fever burden is unknown. We assessed enteric fever seroincidence in rural Niger and evaluated the effect of biannual azithromycin MDA affected.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Principal Findings<\/jats:title>\n                  <jats:p>\n                    This was a secondary analysis of the MORDOR trial (\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT02048007\">NCT02048007<\/jats:ext-link>\n                    ), a cluster-randomized, placebo-controlled study in 30 communities in Dosso Region, Niger. Children aged 1\u201359 months received biannual azithromycin or placebo. Dried blood spots collected at baseline (2015) and Year 5 (2020) were tested for IgA and IgG antibodies against Hemolysin E using kinetic ELISA. Seroincidence was estimated using maximum likelihood methods based on antibody kinetics from blood culture-confirmed enteric fever patients. Samples from 1,417 children were analyzed (423 baseline; 994 Year 5). Overall seroincidence approximately doubled from baseline to Year 5, increasing from 68.5 (95% CI 58.0\u201380.7) to 145.2 (95% CI 132.3\u2013159.3) per 100 person-years in placebo communities and from 74.7 (95% CI 56.5\u201398.7) to 135.2 (95% CI 112.4\u2013162.6) in azithromycin communities, with no significant difference between arms (difference-in-differences \u221216.2; 95% CI -53.1-20.8 ). Among children &lt;2 years, the increase in seroincidence was smaller in the azithromycin arm (37.5; 95% CI: 1.3-73.6) compared to placebo (81.1; 95% CI 54.0-108.2), with a difference-in-differences of \u221243.7 per 100 person-years (95% CI \u221288.8 - 1.5 to 0.02).\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Significance<\/jats:title>\n                  <jats:p>Enteric fever seroincidence among young children in rural Niger is high and increased substantially over the five-year study period. Biannual azithromycin MDA did not significantly reduce overall seroincidence, though a potential attenuation was observed among children under 2 years of age. These findings underscore the importance of Niger\u2019s recent typhoid conjugate vaccine introduction and highlight the value of serosurveillance for monitoring enteric fever infection intensity in settings without blood culture surveillance.<\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.08.03.26359544","type":"posted-content","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:35:22Z","timestamp":1785872122000},"source":"Crossref","is-referenced-by-count":0,"title":["Effect of five years of biannual azithromycin mass drug administration on enteric fever seroincidence in Niger: A randomized control trial"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1886-2699","authenticated-orcid":false,"given":"Kristen","family":"Aiemjoy","sequence":"first","affiliation":[{"name":"Department of Public Health Sciences, University of California Davis School of Medicine, Davis, CA, USA"},{"name":"Department of Immunology and Microbiology, Mahidol University Faculty of Tropical Medicine, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1645-3789","authenticated-orcid":false,"given":"Jessica C","family":"Seidman","sequence":"additional","affiliation":[{"name":"Sabin Vaccine Institute, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M","family":"Arzika","sequence":"additional","affiliation":[{"name":"The Carter Center, Niger, Niamey, Niger"},{"name":"Centre de Recherche et Interventions en Sant\u00e9 Publique, Niamey, Niger"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramatou","family":"Maliki","sequence":"additional","affiliation":[{"name":"The Carter Center, Niger, Niamey, Niger"},{"name":"Centre de Recherche et Interventions en Sant\u00e9 Publique, Niamey, Niger"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amza","family":"Abdou","sequence":"additional","affiliation":[{"name":"Programme Nationale de Sant\u00e9 Oculaire, Niamey, Niger"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas Ezra","family":"Morrison","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, University of California Davis School of Medicine, Davis, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5761-7437","authenticated-orcid":false,"given":"Kristina W","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, University of California Davis School of Medicine, Davis, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise O.","family":"Garrett","sequence":"additional","affiliation":[{"name":"Sabin Vaccine Institute, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Munroe","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Sukri","sequence":"additional","affiliation":[{"name":"Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Lebas","sequence":"additional","affiliation":[{"name":"Francis I. Proctor Foundation, University of California, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Cook","sequence":"additional","affiliation":[{"name":"Francis I. Proctor Foundation, University of California, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin F","family":"Arnold","sequence":"additional","affiliation":[{"name":"Francis I. Proctor Foundation, University of California, San Francisco, CA, USA"},{"name":"Department of Ophthalmology, University of California, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M","family":"Lietman","sequence":"additional","affiliation":[{"name":"Francis I. Proctor Foundation, University of California, San Francisco, CA, USA"},{"name":"Department of Ophthalmology, University of California, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M","family":"Neuzil","sequence":"additional","affiliation":[{"name":"Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R","family":"Andrews","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Palo Alto, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy D","family":"Keenan","sequence":"additional","affiliation":[{"name":"Francis I. Proctor Foundation, University of California, San Francisco, CA, USA"},{"name":"Department of Ophthalmology, University of California, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8881-1849","authenticated-orcid":false,"given":"Richelle C","family":"Charles","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA"},{"name":"Department of Medicine, Harvard Medical School Boston, MA, USA"},{"name":"Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026080604450717000_2026.08.03.26359544v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(18)30685-6"},{"key":"2026080604450717000_2026.08.03.26359544v1.2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy494"},{"key":"2026080604450717000_2026.08.03.26359544v1.3","doi-asserted-by":"crossref","unstructured":"Mogasale V , Ramani E , Mogasale VV , Park J . What proportion of Salmonella Typhi cases are detected by blood culture? A systematic literature review. Ann Clin Microbiol Antimicrob 2016; 15: 32.","DOI":"10.1186\/s12941-016-0147-z"},{"key":"2026080604450717000_2026.08.03.26359544v1.4","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1093\/cid\/ciaa367","article-title":"The Surveillance for Enteric Fever in Asia Project (SEAP), Severe Typhoid Fever Surveillance in Africa (SETA), Surveillance of Enteric Fever in India (SEFI), and Strategic Typhoid Alliance Across Africa and Asia (STRATAA) Population-based Enteric Fever Studies: A Review of Methodological Similarities and Differences","volume":"71","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"2026080604450717000_2026.08.03.26359544v1.5","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1093\/cid\/civ693","article-title":"The Typhoid Fever Surveillance in Africa Program (TSAP): Clinical","volume":"62","year":"2016","journal-title":"Diagnostic, and Epidemiological Methodologies. Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"2026080604450717000_2026.08.03.26359544v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30276-1"},{"key":"2026080604450717000_2026.08.03.26359544v1.7","doi-asserted-by":"crossref","first-page":"e0003056","DOI":"10.1371\/journal.pgph.0003056","article-title":"Typhoid intestinal perforation in Francophone Africa, a scoping review","volume":"4","year":"2024","journal-title":"PLOS Glob Public Health"},{"key":"2026080604450717000_2026.08.03.26359544v1.8","first-page":"131","article-title":"Le fardeau de la perforation typhique de l\u2019intestin gr\u00eale au Niger","volume":"1","year":"2021","journal-title":"The burden of typhoid perforation of the small intestine in Niger"},{"key":"2026080604450717000_2026.08.03.26359544v1.9","doi-asserted-by":"crossref","first-page":"S232","DOI":"10.1093\/cid\/ciaa1309","article-title":"Burden of Ileal Perforations Among Surgical Patients Admitted in Tertiary Care Hospitals of Three Asian countries: Surveillance of Enteric Fever in Asia Project (SEAP), September 2016-September 2019","volume":"71","year":"2020","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"2026080604450717000_2026.08.03.26359544v1.10","doi-asserted-by":"crossref","unstructured":"Murthy S , Hagedoorn NN , Faigan S , Rathan MD , Marchello CS , Crump JA . Complications and mortality of typhoid fever: an updated global systematic review and meta-analysis. Lancet Infect Dis 2025; : S1473-3099(25)00551-1.","DOI":"10.12688\/verixiv.1198.1"},{"key":"2026080604450717000_2026.08.03.26359544v1.11","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0140-6736(25)01335-2","article-title":"Enteric (typhoid and paratyphoid) fever","volume":"406","year":"2025","journal-title":"Lancet Lond Engl"},{"key":"2026080604450717000_2026.08.03.26359544v1.12","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa1817213","article-title":"Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa","volume":"380","year":"2019","journal-title":"N Engl J Med"},{"key":"2026080604450717000_2026.08.03.26359544v1.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1715474"},{"key":"2026080604450717000_2026.08.03.26359544v1.14","first-page":"85","article-title":"Mass Azithromycin Distribution and Cause-Specific Mortality among Children Ages 1-59 Months Old: A Secondary Analysis of a Cluster-Randomized Controlled Trial","volume":"114","year":"2025","journal-title":"Am J Trop Med Hyg"},{"key":"2026080604450717000_2026.08.03.26359544v1.15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.27393"},{"key":"2026080604450717000_2026.08.03.26359544v1.16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007868"},{"key":"2026080604450717000_2026.08.03.26359544v1.17","first-page":"e03481","article-title":"Tracking the Emergence of Azithromycin Resistance in Multiple Genotypes of Typhoidal Salmonella","volume":"12","year":"2021","journal-title":"mBio"},{"key":"2026080604450717000_2026.08.03.26359544v1.18","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1093\/cid\/ciaa1773","article-title":"Spontaneous Emergence of Azithromycin Resistance in Independent Lineages of Salmonella Typhi in Northern India","volume":"72","year":"2021","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"2026080604450717000_2026.08.03.26359544v1.19","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.1093\/cid\/ciaa1323","article-title":"Antimicrobial Resistance in Typhoidal Salmonella: Surveillance for Enteric Fever in Asia Project, 2016-2019","volume":"71","year":"2020","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"2026080604450717000_2026.08.03.26359544v1.20","doi-asserted-by":"crossref","first-page":"e578","DOI":"10.1016\/S2666-5247(22)00114-8","article-title":"Estimating typhoid incidence from community-based serosurveys: a multicohort study","volume":"3","year":"2022","journal-title":"Lancet Microbe"},{"key":"2026080604450717000_2026.08.03.26359544v1.21","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1093\/ofid\/ofad021","article-title":"Seroepidemiology for Enteric Fever: Emerging Approaches and Opportunities","volume":"10","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2026080604450717000_2026.08.03.26359544v1.22","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1128\/CVI.00104-10","article-title":"Characterization of Anti-Salmonella enterica Serotype Typhi Antibody Responses in Bacteremic Bangladeshi Patients by an Immunoaffinity Proteomics-Based Technology","volume":"17","year":"2010","journal-title":"Clin Vaccine Immunol CVI"},{"key":"2026080604450717000_2026.08.03.26359544v1.23","first-page":"2316","article-title":"Seroincidence of Enteric Fever, Juba, South Sudan","volume":"28","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"2026080604450717000_2026.08.03.26359544v1.24","doi-asserted-by":"publisher","DOI":"10.3201\/eid3203.250469"},{"key":"2026080604450717000_2026.08.03.26359544v1.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1715474"},{"key":"2026080604450717000_2026.08.03.26359544v1.26","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/s41467-022-28565-5","article-title":"Effect of biannual azithromycin distribution on antibody responses to malaria, bacterial, and protozoan pathogens in Niger","volume":"13","year":"2022","journal-title":"Nat Commun"},{"key":"2026080604450717000_2026.08.03.26359544v1.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.epidem.2016.04.001"},{"key":"2026080604450717000_2026.08.03.26359544v1.28","doi-asserted-by":"publisher","DOI":"10.1002\/sim.5322"},{"key":"2026080604450717000_2026.08.03.26359544v1.29","doi-asserted-by":"publisher","DOI":"10.12688\/verixiv.3487.1"},{"key":"2026080604450717000_2026.08.03.26359544v1.30","doi-asserted-by":"crossref","first-page":"105547","DOI":"10.1016\/j.landusepol.2021.105547","article-title":"Urban expansion-flood damage nexus: Evidence from the Dosso Region, Niger","volume":"108","year":"2021","journal-title":"Land Use Policy"},{"key":"2026080604450717000_2026.08.03.26359544v1.31","doi-asserted-by":"crossref","first-page":"180629","DOI":"10.1016\/j.scitotenv.2025.180629","article-title":"Association of typhoid fever with floods under climate variability in 82 Belt and Road Initiative countries (2000-2021): A mixed-effects model and implications for water and sanitation infrastructure","volume":"1002","year":"2025","journal-title":"Sci Total Environ"},{"key":"2026080604450717000_2026.08.03.26359544v1.32","doi-asserted-by":"crossref","first-page":"e67544","DOI":"10.2196\/67544","article-title":"Risk Factors for Typhoid Fever: Systematic Review","volume":"11","year":"2025","journal-title":"JMIR Public Health Surveill"},{"key":"2026080604450717000_2026.08.03.26359544v1.33","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.envres.2018.08.030","article-title":"Association between floods and typhoid fever in Yongzhou, China: Effects and vulnerable groups","volume":"167","year":"2018","journal-title":"Environ Res"},{"key":"2026080604450717000_2026.08.03.26359544v1.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.04.022"},{"key":"2026080604450717000_2026.08.03.26359544v1.35","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1016\/S2214-109X(17)30022-0","article-title":"Incidence of invasive salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study","volume":"5","year":"2017","journal-title":"Lancet Glob Health"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.08.03.26359544","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:45:17Z","timestamp":1786016717000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.64898\/2026.08.03.26359544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":35,"URL":"https:\/\/doi.org\/10.64898\/2026.08.03.26359544","relation":{},"subject":[],"published":{"date-parts":[[2026,8,4]]},"subtype":"preprint"}}